Navigation Links
MiMedx to Ring NASDAQ Stock Market Opening Bell
Date:7/9/2013

MARIETTA, Ga., July 9, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that the Company will visit the NASDAQ MarketSite in Times Square and ring the Opening Bell on Friday, July 12, 2013.

Parker H. "Pete" Petit, Chairman and CEO will perform the honorary ringing of the Opening Bell. Bill Taylor, President and COO; Mike Senken, Chief Financial Officer; Debbie Dean, Executive Vice President; Brent Miller, Executive Vice President; Thornton Kuntz, Vice President Human Resources & Administration; and Mike Carlton, Vice President Global Sales, will be joining Mr. Petit in the ceremony.

"Our listing on NASDAQ represents another significant milestone in our strategy to broaden our exposure to the investment community and to increase the trading volume in our stock," said Petit. "Joining the NASDAQ Exchange also comes at an important time for MiMedx as the Company has just become part of the Russell 2000."

The Opening Bell will ring at 9:30 am Eastern Daylight Time and will be televised on CNBC or can be viewed online at www.nasdaq.com.

About the Company 

MiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. "Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include the device technologies HydroF
'/>"/>

SOURCE MiMedx Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MiMedx Group, Inc. to Present at the 6th Annual Canaccord Genuity Cardiovascular, Aesthetics and Metabolic Disorders Conference
2. MiMedx Group Completes $5,000,000 Private Placement
3. MiMedx Group, Inc. Receives CE Certification for Its CollaFix™ Surgical Mesh CD
4. MiMedx to Present at American Academy of Orthopaedic Surgeons Annual Meeting
5. MiMedx Group Announces 2011 Results
6. MiMedx Signs Agreement with Systagenix for Global Distribution of EpiFix®
7. MiMedx Exceeds Revenue Goal for First Quarter of 2012
8. MiMedx Group Announces Record First Quarter Results
9. MiMedx Group, Inc. Announces Release Date for 2012 Second Quarter Results
10. MiMedx Group Announces Record Second Quarter Results
11. MiMedx Group to Present at the Canaccord Genuity Annual Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Telford, England (PRWEB) , ... September 02, 2015 ... ... for drug discovery and life science research, today unveiled Genedata Screener ® ... platform for all in-vitro screening brings to market a rich set of new ...
(Date:9/1/2015)... 1, 2015 Prostate cancer is ... American men. One in seven men will be ... cases are diagnosed annually. That said, not every ... powerful new technique, MRI Fusion Biopsy, to more ... treating only the affected areas and monitoring ...
(Date:9/1/2015)... -- The Dohmen Company today announced the appointment ... Chief Science Officer (CSO) of Dohmen Life Science ... Floyd will lead Dohmen,s growing regulatory consulting practice ... post approval outsourced services in quality, regulatory, pharmacovigilence, ... brings decades of experience leading global regulatory affairs ...
(Date:9/1/2015)... ... , ... A new host-based therapy for Ebola, anthrax and ... Institute and its collaborators. The discovery has the potential to speed to market ... 27 by Scientific Reports, an open access research journal from the publishers of ...
Breaking Biology Technology:New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 2New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 3New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 4September Is Prostate Cancer Awareness Month 2September Is Prostate Cancer Awareness Month 3September Is Prostate Cancer Awareness Month 4Dohmen Life Science Services Appoints Eric Floyd, Ph.D. as Chief Science Officer 2Dohmen Life Science Services Appoints Eric Floyd, Ph.D. as Chief Science Officer 3Scientists Discover New Use for an Old Therapy Inhibiting Deadly Pathogens Including Ebola and Anthrax 2Scientists Discover New Use for an Old Therapy Inhibiting Deadly Pathogens Including Ebola and Anthrax 3Scientists Discover New Use for an Old Therapy Inhibiting Deadly Pathogens Including Ebola and Anthrax 4
... CRANBURY, N.J., April 24 Amicus Therapeutics,Inc. (Nasdaq: ... and,Chief Executive Officer, will present a corporate update at ... 30,2008, at 2:20 p.m. EDT, at the Ritz-Carlton in ... live and may be accessed by visiting,Amicus, website at ...
... Inc.,(Nasdaq: CEPH ) today announced its receipt ... an Abbreviated New Drug Application (ANDA),submitted to the ... Inc., requesting approval to market and sell a ... its Notice,Letter, Watson alleges that the U.S. Patent ...
... Aida,Pharmaceuticals, Inc. (OTC Bulletin Board: AIDA) today ... controlling interest in Jiangsu,Institute of Microbiology Co., Ltd. ... the People,s Republic of China. JSIM,has several drugs ... its development pipeline. This acquisition is expected to ...
Cached Biology Technology:Cephalon Notified of Generic Fentanyl Buccal Tablet Filing 2Cephalon Notified of Generic Fentanyl Buccal Tablet Filing 3Aida Pharmaceuticals, Inc. Announces Completion of Research Institute Acquisition 2
(Date:8/31/2015)... DUBLIN , Aug. 31, 2015 Research ... of the "Saudi Arabia Biomedical Sensors Market - ... offering. The Saudi Arabia Biomedical Sensors ... a CAGR of 3.64% over the period 2014-2020 ... are adaptable to the genetic formulation of each individual. ...
(Date:8/25/2015)... and BELLEVUE, Wash. , ... in advanced robotic systems, announced today it will unveil ... ground vehicle (UGV), at the National Tactical Officers Association ... The Guardian S is the first-ever commercially ... of years of research and in-field trials and is ...
(Date:8/20/2015)... 2015 The wearable technology market has ... and healthy. However, wearable technology has the potential ... help improve diagnostic capabilities and therapeutic outcomes. Today, ... Wearable Technologies Conference 2015 , where Barrett ... in healthcare.    "Over the past ...
Breaking Biology News(10 mins):Saudi Arabia Biomedical Sensors Market Report 2015 - Growth, Trends & Forecasts (2014-2020) 2Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3
... (ORI) scientists help young women reduce the influence of the ... with being thin. ORI scientist Eric Stice, Ph.D. ... reduced the risk for onset of eating disorders by 61% ... for as long as 3 years after the program ended. ...
... NEW YORK (APRIL 29, 2008) Bison can repopulate ... 100 years provided a series of conservation and restoration ... iconic species by the Wildlife Conservation Society and other ... group of conservationists, scientists, ranchers, and Native Americans/First Nations ...
... responsible for the deadly food poisoning disease botulism and ... can also be used as a dreaded biological ... of an ounce can cause muscle paralysis and eventual ... inhibit the destructive action of this neurotoxin the ...
Cached Biology News:Body image program reduces onset of obesity and eating disorders 2Bison can thrive again, study says 2Scientists determine drug target for the most potent botulinum neurotoxin 2
Request Info...
Tight junctions are complexes of proteins that create intercellular boundaries between the plasma membrane domains of epithelial and endothelial cells. Antigen: Synthetic peptide corresponding to...
Myeloid Marker (BM-1)...
Form: Concentrated Applications: ELISA...
Biology Products: